Literature DB >> 31759387

Electric vagal nerve stimulation inhibits inflammation and improves early postoperation cognitive dysfunction in aged rats.

Jun Xiong1, Huijun Wang2, Yin Bao2, Yuliang Guo2, Yongxing Sun3.   

Abstract

BACKGROUND: This study aimed to evaluate effects of electric vagal nerve stimulation on early postoperation cognitive dysfunction in aged rats.
METHODS: A total of 33 male Sprague Dawley rats were selected and assigned randomly to three groups, control group (C, n = 10), splenectomy group (S, n = 10) and splenectomy+vagal nerve stimulation group (SV, n = 13). Behavior and memory of rats were evaluated by Open Field Test and Morris Water Maze. Levels of TNF-α, IL-6 and IL-10 in serum were measured by ELISA. The level of TNF-α protein in hippocampus was assessed by Western blotting. rt-PCR was used to detect mRNA expression of NF-κB in hippocampus.
RESULTS: During anesthesia/operation, vital life signs of rats were stable. In SV group, vagal nerve stimulation decreased heart rate lower than 10% of basic level and kept it at a stable range by regulating stimulation intensity. After stimulation stop, heart rate returned to the basic level again. This indicated that the model of vagal nerve stimulation was successful. Serum levels of TNF-α and IL-6 increased by the operation/anesthesia, but they decreased with vagal nerve stimulation (all P < 0.05). TNF-α protein and mRNA expression of NF-κB in hippocampus were also eliminated by vagal nerve stimulation compared to S group (P < 0.05). Results of Morris Water Maze showed escape latency of postoperation in S group was significantly longer than C group (P < 0.05), and times of crossing platform in S group was lower than that of C group (P < 0.05). Although escape latency of postopration in SV group was shorter than that of S group, there was no significant difference between two groups. Meanwhile there were no significant differences of behavior test in Open Field test between three groups, although vagal nerve stimulation improved partly active explore behavior compared to S group.
CONCLUSION: The inflammation caused by operation and general anesthesia was an important reason of early postoperation cognitive dysfunction, and electric vagal nerve stimulation could inhibit the inflammation. Meanwhile, vagal nerve stimulation could ameliorate early postoperation cognitive dysfunction partly, but its protective effects were not enough and should be studied and improved in future.

Entities:  

Keywords:  Cognitive dysfunction; General anesthesia; Inflammation; Vagus nerve stimulation

Mesh:

Substances:

Year:  2019        PMID: 31759387      PMCID: PMC6875068          DOI: 10.1186/s12871-019-0885-5

Source DB:  PubMed          Journal:  BMC Anesthesiol        ISSN: 1471-2253            Impact factor:   2.217


  32 in total

1.  Modulation of neuroinflammation and memory dysfunction using percutaneous vagus nerve stimulation in mice.

Authors:  William J Huffman; Saraswathi Subramaniyan; Ramona M Rodriguiz; William C Wetsel; Warren M Grill; Niccolò Terrando
Journal:  Brain Stimul       Date:  2018-10-09       Impact factor: 8.955

Review 2.  Vagal-immune interactions involved in cholinergic anti-inflammatory pathway.

Authors:  I Zila; D Mokra; J Kopincova; M Kolomaznik; M Javorka; A Calkovska
Journal:  Physiol Res       Date:  2017-09-22       Impact factor: 1.881

3.  Effects of electroacupuncture at auricular concha region on the depressive status of unpredictable chronic mild stress rat models.

Authors:  Ru-Peng Liu; Ji-Liang Fang; Pei-Jing Rong; Yufeng Zhao; Hong Meng; Hui Ben; Liang Li; Zhan-Xia Huang; Xia Li; Ying-Ge Ma; Bing Zhu
Journal:  Evid Based Complement Alternat Med       Date:  2013-01-29       Impact factor: 2.629

4.  Hypertonic saline for prevention of delirium in geriatric patients who underwent hip surgery.

Authors:  Xi Xin; Fei Xin; Xuguang Chen; Qi Zhang; Yanan Li; Shuping Huo; Chongfu Chang; Qiujun Wang
Journal:  J Neuroinflammation       Date:  2017-11-14       Impact factor: 8.322

5.  Differential hemodynamic and respiratory responses to right and left cervical vagal nerve stimulation in rats.

Authors:  Harald M Stauss
Journal:  Physiol Rep       Date:  2017-04

Review 6.  A review of vagus nerve stimulation as a therapeutic intervention.

Authors:  Rhaya L Johnson; Christopher G Wilson
Journal:  J Inflamm Res       Date:  2018-05-16

7.  Inflammation caused by peripheral immune cells across into injured mouse blood brain barrier can worsen postoperative cognitive dysfunction induced by isoflurane.

Authors:  Honghua Zhu; Wei Liu; Hao Fang
Journal:  BMC Cell Biol       Date:  2018-09-29       Impact factor: 4.241

8.  Connection changes in somatosensory cortex induced by different doses of propofol.

Authors:  Zhaoduan Li; Xingkui Liu; Yi Zhang; Jinshan Shi; Yu Zhang; Peng Xie; Tian Yu
Journal:  PLoS One       Date:  2014-02-07       Impact factor: 3.240

9.  Parecoxib prevents early postoperative cognitive dysfunction in elderly patients undergoing total knee arthroplasty: A double-blind, randomized clinical consort study.

Authors:  Yang-Zi Zhu; Rui Yao; Zhe Zhang; Hui Xu; Li-Wei Wang
Journal:  Medicine (Baltimore)       Date:  2016-07       Impact factor: 1.889

10.  Vagal nerve stimulation triggers widespread responses and alters large-scale functional connectivity in the rat brain.

Authors:  Jiayue Cao; Kun-Han Lu; Terry L Powley; Zhongming Liu
Journal:  PLoS One       Date:  2017-12-14       Impact factor: 3.240

View more
  2 in total

1.  Baroreceptor Modulation of the Cardiovascular System, Pain, Consciousness, and Cognition.

Authors:  Heberto Suarez-Roca; Negmeldeen Mamoun; Martin I Sigurdson; William Maixner
Journal:  Compr Physiol       Date:  2021-02-12       Impact factor: 9.090

2.  Inflammation Disturbed the Tryptophan Catabolites in Hippocampus of Post-operative Fatigue Syndrome Rats via Indoleamine 2,3-Dioxygenas Enzyme and the Improvement Effect of Ginsenoside Rb1.

Authors:  Shu Liu; Yue Cheng; Wei-Zhe Chen; Jin-Xiao Lv; Bei-Shi Zheng; Dong-Dong Huang; Xu-Fen Xia; Zhen Yu
Journal:  Front Neurosci       Date:  2021-08-26       Impact factor: 4.677

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.